Mayo School of Graduate Medical Education, Mayo Clinic, Rochester, Minnesota, USA.
Department of General Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA
BMJ Case Rep. 2022 Apr 8;15(4):e248448. doi: 10.1136/bcr-2021-248448.
A previously healthy and active middle-aged woman acquired COVID-19 as an occupational exposure with subsequent persistent post-COVID-19 symptoms including headache, dyspnoea on exertion, chest pressure, tachycardia, anosmia, parosmia, persistent myalgia, vertigo, cognitive decline and fatigue. She presented to a tertiary medical centre for further evaluation after 9 months of persistent symptoms and had a largely unremarkable workup with the exception of a persistently elevated monocyte chemoattractant protein 1, blunted cardiovagal response and non-specific scattered areas of low-level hypometabolism at the bilateral frontal, left precuneus, occipital and parietal regions on PET scan.
一位既往健康、活跃的中年女性因职业暴露感染了 COVID-19，随后出现持续的 COVID-19 后症状，包括头痛、运动时呼吸困难、胸部压迫感、心动过速、嗅觉丧失、味觉障碍、持续性肌肉痛、眩晕、认知能力下降和疲劳。她在持续症状 9 个月后到一家三级医疗中心进一步就诊，除了单核细胞趋化蛋白 1 持续升高、心脏迷走神经反应迟钝以及 PET 扫描显示双侧额、左楔前叶、枕叶和顶叶区域存在非特异性散在低水平代谢减退区外，其余检查基本正常。
